JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.5% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHCR
4776
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $230K | ﹤0.01% |
145,344
+26,765
| +23% | +$65.7K |
|
|
PSTH
4777
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $230K | ﹤0.01% |
11,500
-157,886
| -93% | -$3.14M |
|
4778
Colony Bankcorp
CBAN
$471M
| $229K | ﹤0.01% |
15,168
+5,162
| +52% | +$86.1K |
|
4779
Stagwell
STGW
$2.28B
| $229K | ﹤0.01% |
42,046
+12,773
| +44% | +$90.5K |
|
4780
CALL
Teck Resources
TECK
$31.3B
| $229K | ﹤0.01% |
7,500
-632,500
| -99% | -$25M |
|
4781
Upland Software
UPLD
$17.9M
| $229K | ﹤0.01% |
1,575
+206
| +15% | +$30.1K |
|
4782
First Business Financial Services
FBIZ
$601M
| $227K | ﹤0.01% |
7,263
+600
| +9% | +$20K |
|
4783
Erasca
ERAS
$6.25B
| $225K | ﹤0.01% |
40,322
-9,892
| -20% | -$64.7K |
|
4784
GDS Holdings
GDS
$6.97B
| $225K | ﹤0.01% |
6,733
-163,242
| -96% | -$5.07M |
|
|
DNMR
4785
DELISTED
Danimer Scientific, Inc.
DNMR
| $225K | ﹤0.01% |
1,231
-451
| -27% | -$81.9K |
|
4786
Hingham Institution for Saving
HIFS
$686M
| $224K | ﹤0.01% |
787
-417
| -35% | -$131K |
|
4787
Stratasys
SSYS
$779M
| $224K | ﹤0.01% |
+11,928
| New | +$235K |
|
4788
Tango Therapeutics
TNGX
$4.32B
| $224K | ﹤0.01% |
49,327
+23,090
| +88% | +$140K |
|
4789
Esquire Financial Holdings
ESQ
$1.59B
| $223K | ﹤0.01% |
6,702
+4,879
| +268% | +$172K |
|
4790
James Hardie Industries
JHX
$17.9B
| $223K | ﹤0.01% |
10,186
+7,260
| +248% | +$192K |
|
|
VLD
4791
DELISTED
Velo3D, Inc.
VLD
| $222K | ﹤0.01% |
4,585
+4,098
| +841% | +$479K |
|
|
KNTE
4792
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $221K | ﹤0.01% |
17,507
-4,363
| -20% | -$40.6K |
|
4793
dLocal
DLO
$4.34B
| $220K | ﹤0.01% |
8,382
+1,087
| +15% | +$27.8K |
|
4794
FRP Holdings
FRPH
$425M
| $220K | ﹤0.01% |
7,288
+898
| +14% | +$26.2K |
|
4795
MiMedx Group
MDXG
$612M
| $219K | ﹤0.01% |
63,309
-14,909
| -19% | -$58.4K |
|
|
EGIO
4796
DELISTED
Edgio, Inc. Common Stock
EGIO
| $219K | ﹤0.01% |
2,371
+294
| +14% | +$42.3K |
|
4797
Anika Therapeutics
ANIK
$283M
| $218K | ﹤0.01% |
9,750
+1,198
| +14% | +$26.7K |
|
|
RNLX
4798
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $218K | ﹤0.01% |
88,410
+43,724
| +98% | +$208K |
|
|
TCDA
4799
CALL
DELISTED
Tricida, Inc. Common Stock
TCDA
| $218K | ﹤0.01% |
+22,500
| New | +$214K |
|
4800
Bionano Genomics
BNGO
$13.5M
| $217K | ﹤0.01% |
262
-104
| -28% | -$107K |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.